Casinto, Jonard G.
HRN: 27-03-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2025
CEFTRIAXONE 1G (VIAL)
04/28/2025
05/04/2025
IV
3g
Od
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes